Sign in
4

Changes in Ownership

WEST PHARMACEUTICAL SERVICES INC Filed Acc 0001562180-23-004626

VP, Chief Accounting Officer acquired 872 shares (option exercise)

  • VP, Chief Accounting Officer acquired 872 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Winters Chad VP, Chief Accounting Officer 2023-05-30 Option exercise +872 $143.43 $125,071 2,320.71 D
Winters Chad VP, Chief Accounting Officer 2023-05-30 Option exercise −872 $339.51 $296,053 1,448.71 D
Derivatives
Winters Chad VP, Chief Accounting Officer 2023-05-30 Option exercise · Stock Options (Right to buy) −872 456 D
Loading xslF345X04/primarydocument.xml…